When people get ready for a bone marrow transplant and take a special drug called busulfan, giving them a common supplement called NAC twice a day might help protect their liver — studies show their liver enzymes, which go up when the liver is stressed, often drop back to normal in about 1 in 3 patients who started with high levels.
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The claim uses 'associated with,' which correctly reflects a correlational finding rather than proving causation. It does not claim NAC prevents liver damage, only that enzyme levels are lower and normalize in a subset — consistent with observational or non-randomized interventional studies. The 30% normalization figure adds specificity without overreaching. No causal language (e.g., 'NAC reduces') is used, making it scientifically cautious and appropriate for the evidence typically available in this clinical context.
More Accurate Statement
“In patients undergoing busulfan-based conditioning for hematopoietic stem cell transplantation, prophylactic administration of N-acetyl-l-cysteine at 100 mg/kg twice daily is associated with significantly lower post-conditioning levels of aspartate transaminase (AST), alanine transaminase (ALT), and alkaline phosphatase (ALP) compared to baseline levels, with normalization of elevated enzymes observed in 30% of patients who initially had abnormal values, suggesting a potential hepatoprotective effect during myeloablative therapy.”
Context Details
Domain
medicine
Population
human
Subject
Patients undergoing busulfan-based conditioning for hematopoietic stem cell transplantation
Action
is associated with
Target
significantly lower post-conditioning levels of AST, ALT, and ALP compared to baseline, with normalization of elevated enzymes in 30% of patients who started with elevated enzymes
Intervention Details
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Evidence from Studies
Supporting (1)
The study gave patients NAC while they were getting a strong chemotherapy drug called busulphan, and found that their liver enzymes went down and returned to normal in many cases — exactly what the claim says.